Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Lixte Biotechnology Holdings ( (LIXT) ) just unveiled an update.
On May 16, 2025, Lixte Biotechnology Holdings, Inc. received a notice of conversion for its 350,000 shares of Series A Convertible Preferred Stock, which were issued in 2015 and 2016. These shares are convertible into 72,917 shares of common stock, impacting the company’s equity structure and potentially affecting its market positioning.
More about Lixte Biotechnology Holdings
Average Trading Volume: 21,438
Technical Sentiment Signal: Sell
Current Market Cap: $3.49M
For a thorough assessment of LIXT stock, go to TipRanks’ Stock Analysis page.